Inoviq (ASX:IIQ) Preferred Dividends : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is Inoviq Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Inoviq's preferred dividends for the six months ended in Dec. 2023 was A$0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Inoviq Preferred Dividends Historical Data

The historical data trend for Inoviq's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inoviq Preferred Dividends Chart

Inoviq Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Preferred Dividends

Get a 7-Day Free Trial

Inoviq Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Inoviq Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Inoviq (ASX:IIQ) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Inoviq (ASX:IIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168

Website

https://www.bard1.com

Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq (ASX:IIQ) Headlines

No Headlines